Lemierre syndrome

Summary

Lemierre syndrome (MONDO:0015306) is a disease. A subtype of commensal bacterial infectious disease — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Prevalence: 1-5 / 10 000 (Denmark) [Orphanet-validated]

Clinical features

Epidemiology

Prevalence records

2 prevalence record(s), Orphanet:

Type	Class	Value	Geography	Validation
Annual incidence	1-5 / 10 000	36	Denmark	Validated
Annual incidence	1-5 / 10 000	10	Europe	Not yet validated

Identifiers

Disease identifiers

Field	Value
Canonical name	Lemierre syndrome
Mondo ID	MONDO:0015306
MeSH	D057831
Orphanet	137839
DOID	DOID:11337
SNOMED CT	52542005
UMLS	C0027537
MedGen	6541
GARD	0006882
MedDRA	10065552
Is cancer (heuristic)	no

Also known as: Lemierre postanginal sepsis · Lemierre syndrome · necrobacillosis · oropharyngeal infection leading to secondary septic thrombophlebitis of the internal jugular vein · postanginal sepsis secondary to orophyngeal infection · septic phlebitis of the internal jugular vein

Disease family

This is a subtype of commensal bacterial infectious disease. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › disease of primarily extrinsic mechanism › infectious disease › bacterial infectious disease › commensal bacterial infectious disease › Lemierre syndrome

Related subtypes (5): toxic shock syndrome, actinomycosis, chlamydia trachomatis infectious disease, gas gangrene, staphylococcal scalded skin syndrome

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.